Current and novel therapeutic molecules and targets in Alzheimer's disease
about
Therapies for Prevention and Treatment of Alzheimer's DiseaseDevelopment and Structural Modification of BACE1 InhibitorsNorovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).Protective Effects of Fucoidan on Aβ25-35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice.Association of Serum Manganese Levels with Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-AnalysisInterleukin-18 -137 G/C and -607 C/A polymorphisms and Alzheimer's disease risk: a meta-analysis.Computational Studies on Acetylcholinesterases.Visual system manifestations of Alzheimer's disease.The Efficacy and Pharmacological Mechanism of Zn7MT3 to Protect against Alzheimer's Disease.Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics.Changing paradigm from one target one ligand towards multi target directed ligand design for key drug targets of Alzheimer disease: An important role of Insilco methods in multi target directed ligands design.Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design.Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay
P2860
Q26740007-4E030910-85DA-409A-ABBC-FB872E57A32AQ28068099-290BF9A8-1A92-4086-B15C-3E375896DCE0Q30835636-2311B2F5-70E4-41A5-87E3-332995A81736Q35999021-67301158-5C6B-4398-8635-880B49A547B9Q37721833-8734B6FB-91C6-4808-98B4-AF49294540A9Q37729700-D0DAF217-958A-4ECC-A900-229A2DECE10FQ38382698-19C9CF66-1ED1-4CB7-B54F-EA697EC275E4Q38630724-8C169589-6E20-4677-9D6F-CD4E2C1B06D7Q39013852-D6C9B142-B942-47E7-BDD6-2346CC59E33CQ46331404-BFF7B4FF-4A1A-4580-B9F8-013EACE6E4E3Q47555674-64AF5ACC-92BC-4161-88D8-096048F90525Q52654613-E6025FBD-6D7A-47D3-BD8B-6C731905CDF7Q52654614-1280E61E-54B7-4E65-84D9-AE0EB3755FDCQ58696563-52B9E7AA-3460-4C94-9167-37C575BC1A2B
P2860
Current and novel therapeutic molecules and targets in Alzheimer's disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Current and novel therapeutic molecules and targets in Alzheimer's disease
@ast
Current and novel therapeutic molecules and targets in Alzheimer's disease
@en
Current and novel therapeutic molecules and targets in Alzheimer's disease
@nl
type
label
Current and novel therapeutic molecules and targets in Alzheimer's disease
@ast
Current and novel therapeutic molecules and targets in Alzheimer's disease
@en
Current and novel therapeutic molecules and targets in Alzheimer's disease
@nl
prefLabel
Current and novel therapeutic molecules and targets in Alzheimer's disease
@ast
Current and novel therapeutic molecules and targets in Alzheimer's disease
@en
Current and novel therapeutic molecules and targets in Alzheimer's disease
@nl
P2093
P50
P3181
P1476
Current and novel therapeutic molecules and targets in Alzheimer's disease
@en
P2093
Chaluveelaveedu Murleedharan Nisha
Chitrangda Silakari
Isha Sharma
Kanukanti Anusha
Nityasha Gupta
Prateek Nair
P3181
P356
10.1016/J.JFMA.2015.04.001
P407
P577
2016-01-01T00:00:00Z